Ligand Pharmaceuticals Statistics
Total Valuation
TADAWUL:9577 has a market cap or net worth of SAR 133.50 million. The enterprise value is 162.81 million.
Market Cap | 133.50M |
Enterprise Value | 162.81M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
TADAWUL:9577 has 50.00 million shares outstanding.
Current Share Class | 50.00M |
Shares Outstanding | 50.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 56.00% |
Owned by Institutions (%) | n/a |
Float | 22.00M |
Valuation Ratios
The trailing PE ratio is 446.15.
PE Ratio | 446.15 |
Forward PE | n/a |
PS Ratio | 2.01 |
PB Ratio | 3.18 |
P/TBV Ratio | 3.18 |
P/FCF Ratio | 30.78 |
P/OCF Ratio | 18.51 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.88, with an EV/FCF ratio of 37.54.
EV / Earnings | 544.10 |
EV / Sales | 2.45 |
EV / EBITDA | 12.88 |
EV / EBIT | 86.44 |
EV / FCF | 37.54 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.74.
Current Ratio | 1.14 |
Quick Ratio | 1.05 |
Debt / Equity | 0.74 |
Debt / EBITDA | 2.46 |
Debt / FCF | 7.16 |
Interest Coverage | 0.61 |
Financial Efficiency
Return on equity (ROE) is 0.72% and return on invested capital (ROIC) is 1.62%.
Return on Equity (ROE) | 0.72% |
Return on Assets (ROA) | 1.36% |
Return on Invested Capital (ROIC) | 1.62% |
Return on Capital Employed (ROCE) | 3.33% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.77 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TADAWUL:9577 has paid 211,842 in taxes.
Income Tax | 211,842 |
Effective Tax Rate | 41.45% |
Stock Price Statistics
The stock price has decreased by -93.57% in the last 52 weeks. The beta is -0.91, so TADAWUL:9577's price volatility has been lower than the market average.
Beta (5Y) | -0.91 |
52-Week Price Change | -93.57% |
50-Day Moving Average | 2.63 |
200-Day Moving Average | 9.95 |
Relative Strength Index (RSI) | 46.66 |
Average Volume (20 Days) | 3,252 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TADAWUL:9577 had revenue of SAR 66.47 million and earned 299,230 in profits. Earnings per share was 0.01.
Revenue | 66.47M |
Gross Profit | 13.67M |
Operating Income | 1.88M |
Pretax Income | 511,072 |
Net Income | 299,230 |
EBITDA | 5.51M |
EBIT | 1.88M |
Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 1.74 million in cash and 31.05 million in debt, giving a net cash position of -29.31 million or -0.59 per share.
Cash & Cash Equivalents | 1.74M |
Total Debt | 31.05M |
Net Cash | -29.31M |
Net Cash Per Share | -0.59 |
Equity (Book Value) | 41.93M |
Book Value Per Share | 0.84 |
Working Capital | 4.45M |
Cash Flow
In the last 12 months, operating cash flow was 7.21 million and capital expenditures -2.87 million, giving a free cash flow of 4.34 million.
Operating Cash Flow | 7.21M |
Capital Expenditures | -2.87M |
Free Cash Flow | 4.34M |
FCF Per Share | 0.09 |
Margins
Gross margin is 20.57%, with operating and profit margins of 2.83% and 0.45%.
Gross Margin | 20.57% |
Operating Margin | 2.83% |
Pretax Margin | 0.77% |
Profit Margin | 0.45% |
EBITDA Margin | 8.28% |
EBIT Margin | 2.83% |
FCF Margin | 6.52% |
Dividends & Yields
TADAWUL:9577 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.22% |
FCF Yield | 3.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on February 13, 2025. It was a forward split with a ratio of 20.
Last Split Date | Feb 13, 2025 |
Split Type | Forward |
Split Ratio | 20 |
Scores
TADAWUL:9577 has an Altman Z-Score of 2.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.3 |
Piotroski F-Score | 4 |